LEAD
Dead / Abandoned — Abandoned — failure to respond (as of 19 Nov 2024)
What this means for you
This application is over — abandoned 06 Nov 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98313499
- Mark type
- Stylized text
- Filed
- 13 Dec 2023
- Abandoned
- 06 Nov 2024
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Owner
- Suzhou Sanegene Bio Inc., Suzhou, Jiangsu, CN
Prosecution history
- 28 Jun 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 28 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 19 Nov 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 19 Nov 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 05 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Aug 2024 — NON-FINAL ACTION E-MAILED
- 05 Aug 2024 — NON-FINAL ACTION WRITTEN
- 02 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Aug 2024 — NON-FINAL ACTION E-MAILED
- 02 Aug 2024 — NON-FINAL ACTION WRITTEN
- 12 Jul 2024 — ASSIGNED TO EXAMINER
- 08 May 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 18 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Dec 2023 — NEW APPLICATION ENTERED